Dear friends and colleagues

We all know that guidelines obligate the testing of new drug against
standard of care but some time in developing countries like Egypt where
standard of care is not available placebo can be considered a standard
of care.

Should RECs allow the standard of care in clinical trial to be the best
available to study population or best available world-wide?

Your thoughts and why?